article thumbnail

What can pharma marketing learn from other regulated industries?

pharmaphorum

In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Within this, the progressive pharma companies are utilising modular content to increase brand standards.

article thumbnail

Can technology help diversify clinical trials?

pharmaphorum

Once stakeholders are confident that technologies are adequately validated, selection based on scientific and ethical considerations can be presented to regulators in accordance with applicable legal and regulatory frameworks. There is a huge opportunity for pharma companies to capitalise on by focusing on increased DEI in clinical trials.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Guido Rasi steps down, handing the running of EMA to Emer Cooke

pharmaphorum

EMA executive director Guido Rasi has ended his second term at the helm of the EU medicines regulator, with Emer Cooke taking the wheel and becoming the first women in the role. Cooke is returning to the EMA after a four-year period as head of medicines regulation at the World Health Organization (WHO). Emer Cooke.

article thumbnail

Thursday pharma headlines

World of DTC Marketing

Amgen CEO Bob Bradway racked up a 2018 pay package of $18.6 million while the company’s pipe line falters. regulators knew about reports of suicidal behavior in men taking the anti-baldness treatment Propecia when they decided not to warn consumers of those potential risks in a 2011 update of the popular drug’s label.

article thumbnail

Q&A: The IND Journey Phase I – Navigating Success

Advarra

The standard for the audit used depends on the type of vendor and would include the applicable regulations and ICH guidelines. Q: What is the typical time period between the submission of the briefing package and the pre-IND meeting? The sponsor-initiated IND is conducted by a pharma company seeking commercial approval.

article thumbnail

European Commission vs Big Pharma, or profit vs access?  

Drug Discovery World

The commission is looking to put more pressure on pharma companies to report such shortages, and to offer a drug’s marketing authorisation to another company before withdrawing it from the market. She also does not believe that the problems with Europe’s medicines can be solved with regulation.

article thumbnail

Brazil: untapped market for big pharma manufacturing

Pharmaceutical Technology

Only a limited number of international pharma companies, however, operate manufacturing sites in the country. Large Brazilian pharma companies already play a major role in distributing Covid-19 vaccines to all of Latin America. French and Italian manufacturers have two companies in Brazil.